Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanofi Consumer Healthcare India Ltd

₹ 4,360 -1.78%
12 Mar 4:01 p.m.
sanofi.in BSE: 544250 NSE: SANOFICONR
About

Incorporated in 2023, Sanofi Consumer Healthcare India Ltd manufactures and trading of drugs & pharmaceutical products.[1]It is a division of Sanofi, a global pharmaceutical company, focusing on over-the-counter (OTC) and consumer healthcare products. [2]

Key Points

Business Overview:[1][2]
SCHIL was formed following its demerger from Sanofi India Limited, to establish a standalone Consumer Healthcare (CHC) business. It operates in the Consumer Healthcare (CHC) sector, providing self-care solutions across various health categories including allergy relief, pain management, and wellness

Website BSE NSE
  • Market Cap ₹ 10,042 Cr.
  • Current Price ₹ 4,360
  • High / Low ₹ 5,954 / 3,950
  • Stock P/E 42.7
  • Book Value ₹ 167
  • Dividend Yield 1.27 %
  • ROCE 152 %
  • ROE 113 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company's working capital requirements have reduced from 109 days to 84.6 days

Cons

  • Stock is trading at 26.2 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
210 225 222 172 160 171 173 221 234 251
116 135 140 109 97 109 109 151 149 161
Operating Profit 95 90 82 64 63 62 64 70 85 90
OPM % 45% 40% 37% 37% 39% 36% 37% 32% 36% 36%
1 1 3 -24 3 2 5 12 3 5
Interest 0 0 0 0 3 0 0 0 1 0
Depreciation 1 1 1 1 2 1 2 3 3 3
Profit before tax 95 90 84 39 61 63 67 79 84 90
Tax % 25% 24% 25% 25% 26% 29% 25% 23% 25% 27%
71 68 63 29 45 44 50 61 63 66
EPS in Rs 12.59 19.54 19.24 21.71 26.36 27.31 28.87
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2023 8m Dec 2024 Mar 2025 TTM
555 724 878 878
337 454 569 569
Operating Profit 219 271 309 309
OPM % 39% 37% 35% 35%
2 -15 25 25
Interest 0 4 2 2
Depreciation 2 4 12 12
Profit before tax 219 247 320 320
Tax % 25% 27% 25%
165 181 240 240
EPS in Rs 78.59 104.25 104.25
Dividend Payout % 6% 70% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 21%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -9%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 113%

Balance Sheet

Figures in Rs. Crores

Dec 2023 Dec 2024 Jun 2025
Equity Capital 2 23 23
Reserves 206 250 234
0 20 28
138 138 137
Total Liabilities 345 431 422
5 29 42
CWIP 3 1 0
Investments 0 0 0
338 402 380
Total Assets 345 431 422

Cash Flows

Figures in Rs. Crores

Dec 2023 Dec 2024 Mar 2025
-0 439
0 2
2 -116
Net Cash Flow 2 325

Ratios

Figures in Rs. Crores

Dec 2023 Dec 2024 Mar 2025
Debtor Days 21 7
Inventory Days 232 80
Days Payable 144 138
Cash Conversion Cycle 109 -51
Working Capital Days 134 -33
ROCE % 111%

Insights

In beta
Dec 2023Dec 2024
Allegra Market Share (Allergy Category)
%

Log in to view insights

Please log in to see hidden values.

Login
Avil Market Share (Allergy Category)
%
City Reach
Number of Cities
Combiflam Annual Sales Volume
Million Tablets
Combiflam Market Share (Pain Category)
%
Combiflam Sales Velocity
Strips per minute
DePURA Market Share (Vitamin D Category)
%
Total Employees
Number

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
60.40% 60.40% 60.40% 60.40% 71.27% 71.27% 71.27%
6.03% 5.22% 4.42% 4.52% 3.24% 2.94% 2.83%
22.60% 23.83% 25.35% 25.48% 16.89% 17.21% 17.33%
10.98% 10.56% 9.84% 9.59% 8.59% 8.58% 8.57%
No. of Shareholders 61,09158,58255,73451,85949,63248,80848,075

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports